您当前的位置:
首页 >
文章列表页 >
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
- “放射药物治疗重塑肿瘤微环境以提高癌症免疫力,而缺氧和坚硬的细胞外基质限制了其疗效。研究人员开发了免疫检查点抑制剂和CAR-T细胞的联合策略,推进了癌症的精准治疗。”
- 军事医学研究(英文) 2026年
DOI: 10.1016/j.mmr.2026.100038
录用:2026-04-26
移动端阅览
AI导读
HTML全文
图( 8 ) 表( 4 )
参考文献
出版信息
数据统计
35
浏览量
17
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Engineering of functional auditory neurons from human induced pluripotent stem cells
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Frostbite: diagnosis, treatment, prognosis, and future directions
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
相关作者
Lu Tang
Zhong-Pei Huang
Heng Mei
Yu Hu
相关机构
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease
Key Laboratory of Biological Targeted Therapy, the Ministry of Education
Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

